| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/02/2005 | EP1130966B1 Antiparasitic formulations |
| 02/02/2005 | EP1023077B1 Opthalmic composition |
| 02/02/2005 | EP0729357B1 Microencapsulated 1,2-benzazoles |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575186A Hard capsules based on polysaccharide and method for the production thereof |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1575175A Drug formulation having improved oral tolerability |
| 02/02/2005 | CN1575165A Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1575132A Process for preparing chewing gum containing a nutritional supplemental |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572326A Therapeutic compositions including bio-availability enhancers |
| 02/02/2005 | CN1572303A Methods and compositions for the prevention of tolerance to medications |
| 02/02/2005 | CN1572300A Avermectin containing parasite resisitant long-acting injectio |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187312C Amorphous compounds and their pharmaceutical compositions |
| 02/02/2005 | CN1187106C Dual adhesive transdermal drug delivery system |
| 02/02/2005 | CN1187094C Polyol-IFN-beta conjugates |
| 02/02/2005 | CN1187093C Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent |
| 02/02/2005 | CN1187092C Slow-released carrier with nano structure for drug |
| 02/02/2005 | CN1187091C Oral vanadium replenishing agent with bimetallic oxide as carrier and its preparation and operation guide |
| 02/02/2005 | CN1187052C Sustained release microsphere containing stavudine |
| 02/02/2005 | CN1187049C Patches containing buprenorphine |
| 02/02/2005 | CN1187044C Storable active substance concentrate containing formoterol |
| 02/02/2005 | CN1187042C Plaster which contains steroids and its production method and uses |
| 02/02/2005 | CN1187039C High potency dihydroergotamine compositions |
| 02/01/2005 | US6849729 Neutralizaing with acid; applying to skin; confining moisture |
| 02/01/2005 | US6849715 Agents useful for inactivation of Ras subfamily proteins |
| 02/01/2005 | US6849655 Aqueous liquid formulations |
| 02/01/2005 | US6849645 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 02/01/2005 | US6849286 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants |
| 02/01/2005 | US6849274 Mixture of anhydrous calcium lactate; calcium oxide and anhydrous or calcined magnesium sulfate which, when added to a food containing releasably bound water, provides a dessicating effect |
| 02/01/2005 | US6849272 Endosomal lysing polymer having ortho-ester, hydrazone, and/or cis-acetonyl groups that are released upon hydrolysis and a proton acceptor ionizable functional moiety |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | US6849269 Enteric-coated mixture of a poorly water soluble drug and a phospholipid |
| 02/01/2005 | US6849263 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
| 02/01/2005 | US6848197 Spray dried particles having specified aerodynamic characteristics are produced by atomizing a liquid feed and contacting the liquid feed with a drying gas, such as, for example, air or nitrogen. |
| 02/01/2005 | CA2296080C Ophthalmic compositions containing galactomannan polymers and borate |
| 02/01/2005 | CA2270074C Electrically conductive adhesive hydrogels |
| 02/01/2005 | CA2147281C Method and compositions for removing an alginate from a cutaneous substrate |
| 02/01/2005 | CA2133324C Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 02/01/2005 | CA2127740C Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it |
| 02/01/2005 | CA2083159C The combination of growth hormone and insulin-like growth factor-1 enhances growth |
| 01/27/2005 | WO2005008253A2 Stable compositions for measuring human natriuretic peptides |
| 01/27/2005 | WO2005007854A2 Polycationic compositions for cellular delivery of polynucleotides |
| 01/27/2005 | WO2005007819A2 Charge-dynamic polymers and delivery of anionic compounds |
| 01/27/2005 | WO2005007798A2 Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione |
| 01/27/2005 | WO2005007714A1 Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| 01/27/2005 | WO2005007664A1 3-α-GLYCOSYLα, α-TREHALOSE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 01/27/2005 | WO2005007197A2 Conjugated biological molecules and their preparation |
| 01/27/2005 | WO2005007195A1 Poly-4-hydroxybutyrate matrices for sustained drug delivery |
| 01/27/2005 | WO2005007185A2 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 01/27/2005 | WO2005007168A1 A stable clozapine suspension formulation |
| 01/27/2005 | WO2005007153A1 A composition of amino acid-iodine complex and methods for preparing and application |
| 01/27/2005 | WO2005007129A2 Topical formulations with bioactive components |
| 01/27/2005 | WO2005007122A2 Polymer stabilization |
| 01/27/2005 | WO2005007077A2 Antimicrobial silver ion complex resinates |
| 01/27/2005 | WO2005007069A2 Soft gel formulations for saquinavir |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2004104492A3 Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| 01/27/2005 | WO2004096234A3 Kinase inhibitor phosphonate conjugates |
| 01/27/2005 | WO2004091528A3 Delivery systems of homogeneous thermoreversible alginate films |
| 01/27/2005 | WO2004087043B1 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 01/27/2005 | WO2004084950A3 Cell targeting methods and compositions |
| 01/27/2005 | WO2004084861A3 Angiogenesis promotion by prostaglandin compositions and methods |
| 01/27/2005 | WO2004082580A3 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/27/2005 | WO2004069208A3 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 01/27/2005 | WO2004064757A3 Absorption enhancing agents |
| 01/27/2005 | WO2004060406A3 Polymeric reagents comprising a ketone or a related functional group |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | WO2004037341A3 Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
| 01/27/2005 | WO2004010998A8 Sustained-release tablet comprising reboxetine |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050021174 Method and system for producing customized cosmetic and pharmaceutical formulations on demand |
| 01/27/2005 | US20050020869 Methods of enhancing radiation effects with metal nanoparticles |
| 01/27/2005 | US20050020854 For use as cleaning and foaming agents and as emulsifiers |
| 01/27/2005 | US20050020815 Gentically engineered serum albumin comprising three-amino acid truncation at its n-terminal and decreased receptivity for trace metals for use in cosmetic and pharmaceutical preparations |
| 01/27/2005 | US20050020810 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 01/27/2005 | US20050020808 Biodegradable polyphosphazene polymer with sol-gel behavior; a temperature change in aqueous solution in a temperature near a body temperature |
| 01/27/2005 | US20050020692 Injections for treatment of heaves by breathing or injection through skinfor antiinflammatory agents, tablets, capsules, aerosols of racemic mixtures for treatment in horses |
| 01/27/2005 | US20050020690 Infiltration of capsaicin into surgical sites and open wounds |
| 01/27/2005 | US20050020688 Mixing nimesulfide with vinyl glyceol for topical drug for antiinflammatory agents |
| 01/27/2005 | US20050020671 Core comprises first active ingredient, coating comprising second active ingredient incompatible with first and barrier between core and coating which prevents physical contact between them, characterised in that barrier is formed on core by film-coating and coating is formed by press-coating |
| 01/27/2005 | US20050020633 Nitroxide radioprotector formulations and methods of use |
| 01/27/2005 | US20050020615 Mixture of rapamycin with tertiary butanol or ethanol; anticancer agents, multiple sclerosis, rheumatic disease |
| 01/27/2005 | US20050020552 Pharmaceutical composition and method for transdermal drug delivery |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/27/2005 | US20050020539 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 01/27/2005 | US20050020525 first nucleotide sequence complementary to a target RNA sequence or a portion thereof, and a second sequence chemically modified so that it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; pharmaceutical use such as viricide |
| 01/27/2005 | US20050020507 mixing acidic dextrose concentrate and buffer to form a ready-to-use solution; enhanced biocompatibility |
| 01/27/2005 | US20050020502 Sincalide formulations |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050020491 A decorin core protein or a fragment covalently linked to a galactosaminoglycan polysaccharide, and the decorin core protein acts as an anticoagulant and as a carrier for the delivery of an antithrombotic galactosaminoglycan to fibrinogen. |
| 01/27/2005 | US20050020485 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
| 01/27/2005 | US20050019926 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 01/27/2005 | US20050019923 Nucleotide sequences comprising cationic polypropylenimine dendrimer and diaminobutane core for use as tool in delivery of drug agents and tissue targeted therapy |
| 01/27/2005 | US20050019845 Immunoconjugates of antibodies and cytotoxic agents (ricin, taxol); for treament of cancer and metastasis; tomography |